1. Gross TM, Bode BW, Einhorn D, Kayne DM, Reed JH, White NH, Mastrototaro JJ: Performance evaluation of the MiniMed continuous glucose monitoring system during patient home use. Diabetes Technol Ther. 2000; 2: 49-56.
2. Potts RO, Tamada JA, Tierney MJ: Glucose monitoring by reverse iontophoresis. Diabetes Metab Res Rev. 2002; 18 Suppl 1: S49-53.
3. Bode B, Gross K, Rikalo N, Schwartz S, Wahl T, Page C, Gross T, Mastrototaro J: Alarms based on real-time sensor glucose values alert patients to hypo- and hyperglycemia: the guardian continuous monitoring system. Diabetes Technol Ther. 2004; 6: 105-113.
4. Deiss D, Bolinder J, Riveline JP, Battelino T, Bosi E, Tubiana-Rufi N, Kerr D, Phillip M. Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diabetes Care. 2006; 29 : 2730-2732.
5. Maran A, Crepaldi C, Tiengo A, Grassi G, Vitali E, Pagano G, Bistoni S, Calabrese G, Santeusanio F, Leonetti F, Ribaudo M, Di Mario U, Annuzzi G, Genovese S, Riccardi G, Previti M, Cucinotta D, Giorgino F, Bellomo A, Giorgino R, Poscia A, Varalli M: Continuous subcutaneous glucose monitoring in diabetic patients: a multicenter analysis. Diabetes Care 2002; 25: 347-352
6. Garg SK, Schwartz S, Edelman SV. Improved glucose excursions using an implantable real-time continuous glucose sensor in adults with type 1 diabetes. Diabetes Care. 2004; 27: 734-738.)
7. Feldman B, Brazg R, Schwartz S, Weinstein R.: A continuous glucose sensor based on wired enzyme technology -- results from a 3-day trial in patients with type 1 diabetes. Diabetes Technol Ther. 2003; 5: 769-779.
8. Diabetes Research in Children Network (DirecNet) Study Group: The accuracy of the GlucoWatch G2 biographer in children with type 1 diabetes: results of the diabetes research in children network (DirecNet) accuracy study. Diabetes Technol Ther. 2003; 5: 791-800.
9. Tansey MJ, Beck RW, Buckingham BA, Mauras N, Fiallo-Scharer R, Xing D, Killman C, Tamborlane WV, Ruedy KJ.; The Diabetes Research in Children Network (DirecNet) Study Group. Accuracy of the modified Continuous Glucose Monitoring System (CGMS) sensor in an outpatient setting: results from a diabetes research in children network (DirecNet) study. Diabetes Technol Ther. 2005;7:109-14.
10. Klonoff, DC Technology to treat hyperglycemia in trauma patients. J Diabetes Sci Technol. 2007:1: 151-152.
11. Nichols, JH, Klonoff DC: The need for performance standards for continuous glucose monitors. J D Sci Technol. 2007:1:92-95.
12. Deiss D, Bolinder J, Riveline JP, Battelino T, Bosi E, Tubiana-Rufi N, Kerr D, Phillip M. Improved Glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diabetes Care. 2006;29:2730-2732.
13. Garg SK, Schwartz S, Edelman SV. Improved glucose excursions using an implantable real-time continuous glucose sensor in adults with type 1 diabetes. Diabetes Care. 2004; 27: 734-738.)
14. Garg S, Jovanovic L: Relationship of fasting and hourly blood glucose levels to HbA1c values: safety, accuracy, and improvements in glucose profiles obtained using a 7-day continuous glucose sensor. Diabetes Care 2006: 29: 2644-2649.
15. Wilson DM, Beck RW, Tamborlane WV, Dontchex MJ, Kollman C, Chase P, Fox LA, Ruedy KJ, Tsalikian E, Weinzimer SA; DirecNet Study Group. The accuracy of the FreeStyle Navigator continuous glucose monitoring system in children with type 1 diabetes. Diabetes Care, 2007;30:59-64.
16. Halvorson M, Carpenter S, Kaiserman K, Kaufman FR. A pilot trial in pediatrics with the sensor-augmented pump: combining real-time continuous glucose monitoring with the insulin pump. J Pediatr. 2007;150:103-105.e1.
17. Cembrowski G. Alternate site testing: first do no harm. Diabetes Technol Ther 2002;4:45-47.
18. Khalil OS. Non-invasive glucose measurement technologies: an update from 1999 to the dawn of the new millennium. Diabetes Technol Ther. 2004 ;6:660-697
19. Saudek CD, Derr RL, Kalyani RR. Assessing glycemia in diabetes using self-monitoring blood glucose and hemoglobin A1c. JAMA. 2006;295:1688-1697.
20. Bode B, Irvin B, Pierce J, Allen M, Clark A. Advances in hemoglobin A1c point of care technology. J Diabetes Sci Technol 2007; 1, 405 - 411
21. Miedema K. Standardization of HbA1c and Optimal Range of Monitoring. Scand J Clin Lab Invest Suppl. 2005;240:61-72.
22. Cohen RM, Snieder H, Lindsell CJ, Beyan H, Hawa MI, Blinko S, Edwards R, Spector TD, Leslie RD. Evidence for independent heritability of the glycation gap (glycosylation gap) fraction of HbA1c in nondiabetic twins. Diabetes Care. 2006; 29:1739-1743
23. Chalew SA, McCarter RJ, Thomas J, Thomson JL, Hempe JM. A comparison of the Glycosylation Gap and Hemoglobin Glycation Index in patients with diabetes. J Diabetes Complications. 2005;19:218-222
24. Lachin JM, Genuth S, Nathan DM, Rutledge BN. The Hemoglobin Glycation Index is Not an Independent Predictor of the Risk of Microvascular Complications in the Diabetes Control and Complications Trial. Diabetes. 2007 Mar 14
25. Kilpatrick ES, Rigby AS, Atkin SL. Variability in the Relationship between Mean Plasma Glucose and HbA1c: Implications for the Assessment of Glycemic Control. Clin Chem. 2007 Mar 23.
26. Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, Colette C. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA. 2006;295:1681-1687.
27. Khan HA, Sobki SH, Alhomida AS. Fluctuations in fasting blood glucose and serum fructosamine in pregnant women monitored on successive antenatal visits. Clin Exp Med. 2006;6:134-137.
28. Takahashi S, Uchino H, Shimizu T, Kanazawa A, Tamura Y, Sakai K, Watada H, Hirose T, Kawamori R, Tanaka Y. Comparison of Glycated Albumin (GA) and Glycated Hemoglobin (HbA1c) in Type 2 Diabetic Patients: Usefulness of GA for Evaluation of Short-term Changes in Glycemic Control. Endocr J. 2007;54:139-1344.
29. Dungan KM, Buse JB, Largay J, Kelly MM, Button EA, Kato S, Wittlin S. 1,5-anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes. Diabetes Care. 2006;29:1214-1219.
30. Lutgers HL, Graaff R, Links TP, Ubink-Veltmaat LJ, Bilo HJ, Gans RO, Smit AJ. Skin autofluorescence as a noninvasive marker of vascular damage in patients with type 2 diabetes. Diabetes Care. 2006;29:2654-2659.
31. Maynard JD, Rohrscheib M, Way JF, Nguyen CM, Ediger MN. Noninvasive Type 2 Diabetes Screening: Superior Sensitivity to Fasting Plasma Glucose and Glycosylated Hemoglobin. Diabetes Care. 2007 Mar 2.
32. Klonoff DC. Technology for portable measurement of blood lactate. Diabetes Technol Ther. 2003;5:929-931
33. Klonoff DC. The Artificial Pancreas: How Sweet Engineering Will Solve Bitter Problems. J Diabetes Sci Technol, 2007 1: 72 - 81.
34. Khatib FH, Russell SJ, Nathan DM, Sutherlin RG, Damiano ER A bihormonal closed-loop artificial pancreas for type 1 diabetes.Sci Transl Med. 2010 Apr 14;2El-.(27):27ra27.